Virtuleap raises $2.5M to use VR and AI for brain health

Virtuleap has raised $2.5 million to make use of digital actuality and AI to enhance mind well being in a product dubbed Improve VR.

GED Ventures Portugal invested in Virtuleap, a startup specializing in healthtech and edtech. Virtuleap has developed a group of digital actuality video games that can be utilized to guage and enhance numerous cognitive talents, equivalent to reminiscence, consideration, motor management abilities and spatial orientation.

The corporate mentioned it could present important scientific findings for mind well being screening and profiling by gathering knowledge on a single platform.

Neuroscientists have developed these quick, intense, and enjoyable video games, they usually function translations of neuropsychological evaluation instruments, that are then analyzed utilizing synthetic intelligence studying instruments.

The Improve VR program, developed by Virtuleap, goals to supply a “health club for the thoughts” accessible to everybody, and doubtlessly serve sooner or later as a therapeutic for studying challenges like ADHD and different cognitive problems. The workouts are divided into seven cognitive classes: reminiscence, consideration, info processing, psychological flexibility, problem-solving, motor management and spatial orientation.

The corporate can also be constructing an upcoming second product, Cogniclear VR, which it plans to launch in 2024. It’s a digital reality-based cognitive screening device that’s being co-designed with companions like Lusíadas Saúde and Roche Portugal to be delicate sufficient to doubtlessly detect a cognitive dysfunction so early in its tracks (e.g. subjective cognitive decline) to allow earlier intervention for higher well being outcomes regarding cognitive sicknesses like Alzheimer’s illness.

Amir Bozorgzadeh, CEO of Virtuleap, mentioned in an announcement this funding “permits us to ramp up improvement and commercialization of our frontier VR cognitive options at a time by which an impending ‘cognition disaster’ is effectively underway.”

The corporate is engaged on creating AI studying algorithms utilizing the volumetric datasets of psychometric, bodily, and physiological knowledge (250K+ knowledge factors each 3 minutes) to doubtlessly correlate cognitive efficiency to psychological well being.

GED Ventures Portugal led this funding spherical, reinforcing its dedication to #Tech4Purpose.

Bibi Sattar Marques, companion at GED Ventures Portugal, mentioned in an announcement, “the funding in Virtuleap displays the corporate’s strategic method of investing in expertise that positively impacts folks’s lives, notably their well being. By bringing collectively expertise and well-being, we’re dedicated to pave the way in which for a brand new period in psychological well being that’s accessible to everybody.”

GED is an unbiased and worldwide monetary group in Europe, the USA of America, and South America. Presently, it manages greater than a billion euros in property within the areas of enterprise, personal fairness, and Infrastructure.

The flagship product, Improve VR, has gained over 60,000 early registered customers with none advertising efforts. Its international attain is clear with its availability in main VR app shops and translations in 5 languages: English, Spanish, Portuguese, Japanese, and Chinese language. The corporate might be including German, French, and Dutch by Q1 2024.

Scientific credibility

The corporate mentioned its dedication to analysis is clear with 4 revealed papers, one in all which showcases a promising pilot research. This research reveals {our capability} to reinforce processing pace in college students with ADHD.

And the corporate has secured $1.8 million in in-bound business agreements (mixture of pilots, licensing, and improvement assist) with firms like Penumbra, HP, and BehaVR, underscoring the business’s demand for our transformative expertise.

In collaboration with Roche, the agency is growing Cogniclear VR. This groundbreaking device is about to revolutionize early cognitive sickness detection, doubtlessly outpacing any present resolution in pace and accuracy.